These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25955909)

  • 1. SURVIVAL IN CERVICAL CANCER PATIENTS TREATED BY MINIMALLY INVASIVE SURGERY: IGCS-0066 Cervical Cancer.
    Pessini S; Silveira GP; Salcedo MP; Anselmi MC
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():23. PubMed ID: 25955909
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Minimally Invasive Surgery and Abdominal Surgery Among Patients With Cervical Cancer.
    Ratiu D; Luncescu C; Morgenstern B; Eichler C; Grüttner B; Ludwig S; Mallmann P; Thangarajah F
    Anticancer Res; 2019 May; 39(5):2661-2664. PubMed ID: 31092465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROBOTIC SURGERY INCREASES PATIENT's ACCESS TO MINIMALLY INVASIVE SURGERY FOR HYSTERECTOMIES: IGCS-0098 Uterine Cancer, including Sarcoma.
    Forde G; Chang J; A Z; Tewari K; Bristow R
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():74. PubMed ID: 25955949
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Kim SI; Cho JH; Seol A; Kim YI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    Gynecol Oncol; 2019 Apr; 153(1):3-12. PubMed ID: 30642625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SURVIVAL OF CERVICAL CANCER TYPE SQUAMOUS AND ADENOCARCINOMA IN PATIENTS FROM THE NATIONAL CANCER INSTITUTE, BETWEEN 2009-2013, CHILE: IGCS-0050 Cervical Cancer.
    Gayan P; Villalobos M; Wendling C; Sierra C; Valencia O; Carcamo M; Prado S; Selman A; Garrido J
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():17. PubMed ID: 25955904
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimization of curative surgery for treatment of early cervical cancer: a review.
    Arimoto T; Kawana K; Adachi K; Ikeda Y; Nagasaka K; Tsuruga T; Yamashita A; Oda K; Ishikawa M; Kasamatsu T; Onda T; Konishi I; Yoshikawa H; Yaegashi N;
    Jpn J Clin Oncol; 2015 Jul; 45(7):611-6. PubMed ID: 25888708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical vertebroplasty for osteolytic metastases as a minimally invasive therapeutic option in oncological surgery: outcome in 14 cases.
    Stangenberg M; Viezens L; Eicker SO; Mohme M; Mende KC; Dreimann M
    Neurosurg Focus; 2017 Aug; 43(2):E3. PubMed ID: 28760030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates over time and regional variation of radical minimally invasive surgery for cervical cancer: A population based study.
    Willows K; Kupets R; Diong C; Vicus D; Covens A; Gien LT
    Gynecol Oncol; 2019 Aug; 154(2):338-344. PubMed ID: 31171407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREATMENT OUTCOMES OF PATIENTS WITH EARLY STAGE CERVICAL CANCER TREATED WITH LAPAROTOMY COMPARED TO ROBOTICALLY ASSISTED LAPAROSCOPIC APPROACH: IGCS-0089 Cervical Cancer.
    Seader K; Rao S; Hemida Y; Hashemi E; Pitter M; Anderson P; Sommers G
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():32-3. PubMed ID: 25955917
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimally invasive cervical spine surgery.
    Skovrlj B; Qureshi SA
    J Neurosurg Sci; 2017 Jun; 61(3):325-334. PubMed ID: 27787486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical trachelectomy in early-stage cervical cancer: A comparison of laparotomy and minimally invasive surgery.
    Vieira MA; Rendón GJ; Munsell M; Echeverri L; Frumovitz M; Schmeler KM; Pareja R; Escobar PF; Reis RD; Ramirez PT
    Gynecol Oncol; 2015 Sep; 138(3):585-9. PubMed ID: 26095894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIOMARKER ASSESSMENT IN CERVICAL UTERINE CANCER: IGCS-0055 Cervical Cancer.
    Medina-Berlanga R; Blancas S; Santos L
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():20. PubMed ID: 25955907
    [No Abstract]   [Full Text] [Related]  

  • 13. ATYPICAL HEPATECTOMY FOR LIVER METASTASES FROM CERVICAL CANCER: IGCS-0029 Cervical Cancer.
    Bacabasa N; Balescu I; Stoica C
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():12-4. PubMed ID: 25955901
    [No Abstract]   [Full Text] [Related]  

  • 14. APOPTOTIC PATHWAY OF ZINC ON CERVICAL CANCER CELL LINE: IGCS-0020 Cervical Cancer.
    Bae SN; Ki EY; Chang HK; Lee YK; Lee KH
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():9. PubMed ID: 25955898
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimally Invasive Radical Hysterectomy for Cervical Cancer Is Associated With Reduced Morbidity and Similar Survival Outcomes Compared With Laparotomy.
    Diver E; Hinchcliff E; Gockley A; Melamed A; Contrino L; Feldman S; Growdon W
    J Minim Invasive Gynecol; 2017; 24(3):402-406. PubMed ID: 28011096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLINICAL ADVANTAGES OF NERVE-SPARING RADICAL HYSTERECTOMY OF CERVICAL CANCER: IGCS-0096 Cervical Cancer.
    Parry S; Riesle H; Bazan C
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():37. PubMed ID: 25955920
    [No Abstract]   [Full Text] [Related]  

  • 17. UTERINE CERVICAL CANCER RECURRENCE PATTERN IN HIGUERAS HOSPITAL,TALCAHUANO - CHILE,BETWEEN 2003 AND 2014: IGCS-0052 Cervical Cancer.
    Vigueras A; Hinostroza M; Araneda J; Moraga A
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():18. PubMed ID: 25955905
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effectiveness of minimally invasive and abdominal radical hysterectomy for cervical cancer.
    Wright JD; Herzog TJ; Neugut AI; Burke WM; Lu YS; Lewin SN; Hershman DL
    Gynecol Oncol; 2012 Oct; 127(1):11-7. PubMed ID: 22735788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CERVICAL CANCER AND PREGNANCY: THREE CASES DURING 2014 IN CARLOS VAN BUREN HOSPITAL, VALPARAISO-CHILE: IGCS-0072 Cervical Cancer.
    Riesle H; Parry S; Bazan C
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():25. PubMed ID: 25955911
    [No Abstract]   [Full Text] [Related]  

  • 20. THE VALUE OF CYTOKERATIN 19 AND HUMAN PAPILLOMA VIRUS DNA AS MICROMETASTASIS MARKERS IN CERVICAL CANCER PATIENTS WITH INTERMEDIATE RISK FACTORS: IGCS-0022 Cervical Cancer.
    Gy DH; Kim MJ; Lee YH; Chong GO; Lee YS; Cho YL; Park JY
    Int J Gynecol Cancer; 2015 May; 25 Suppl 1():10. PubMed ID: 25955899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.